Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Aspirin resistance is more common in lacunar strokes than embolic strokes and is related to stroke severity.

Englyst NA, Horsfield G, Kwan J, Byrne CD.

J Cereb Blood Flow Metab. 2008 Jun;28(6):1196-203. doi: 10.1038/jcbfm.2008.9. Epub 2008 Mar 5.

PMID:
18319729
2.

Immuno-inflammatory activation in acute cardio-embolic strokes in comparison with other subtypes of ischaemic stroke.

Licata G, Tuttolomondo A, Di Raimondo D, Corrao S, Di Sciacca R, Pinto A.

Thromb Haemost. 2009 May;101(5):929-37.

PMID:
19404547
3.

Abnormal blood pressure circadian rhythm in acute ischaemic stroke: are lacunar strokes really different?

Castilla-Guerra L, Espino-Montoro A, Fernández-Moreno MC, López-Chozas JM.

Int J Stroke. 2009 Aug;4(4):257-61. doi: 10.1111/j.1747-4949.2009.00314.x.

PMID:
19689751
4.

Moderate hyperglycaemia is associated with favourable outcome in acute lacunar stroke.

Uyttenboogaart M, Koch MW, Stewart RE, Vroomen PC, Luijckx GJ, De Keyser J.

Brain. 2007 Jun;130(Pt 6):1626-30.

PMID:
17525141
5.

The clinical importance of laboratory-defined aspirin resistance in patients presenting with non-ST elevation acute coronary syndromes.

Acikel S, Yildirir A, Aydinalp A, Bal U, Kaynar G, Ozin B, Muderrisoglu H.

Blood Coagul Fibrinolysis. 2009 Sep;20(6):427-32. doi: 10.1097/MBC.0b013e32832c87b3.

PMID:
19542882
6.

Mean platelet volume (MPV) increase during acute non-lacunar ischemic strokes.

Muscari A, Puddu GM, Cenni A, Silvestri MG, Giuzio R, Rosati M, Santoro N, Bianchi G, Magalotti D, Zoli M.

Thromb Res. 2009 Feb;123(4):587-91. doi: 10.1016/j.thromres.2008.03.025. Epub 2008 May 9.

PMID:
18472144
7.

Interleukin-18 in acute ischaemic stroke patients.

Zaremba J, Losy J.

Neurol Sci. 2003 Oct;24(3):117-24.

PMID:
14600822
8.

Cognitive impairment and seizures in patients with lacunar strokes.

De Reuck J, Van Maele G.

Eur Neurol. 2009;61(3):159-63. doi: 10.1159/000186507. Epub 2008 Dec 18.

PMID:
19092253
9.

Aspirin resistance in South African Caucasian patients with thrombotic cerebrovascular events.

Bernstein PL, Jacobson BF, Connor MD, Becker PJ.

J Neurol Sci. 2009 Feb 15;277(1-2):80-2. doi: 10.1016/j.jns.2008.10.013. Epub 2008 Nov 17.

PMID:
19013588
10.

Plasma levels of inflammatory and thrombotic/fibrinolytic markers in acute ischemic strokes: relationship with TOAST subtype, outcome and infarct site.

Tuttolomondo A, Di Sciacca R, Di Raimondo D, Serio A, D'Aguanno G, La Placa S, Pecoraro R, Arnao V, Marino L, Monaco S, Natalè E, Licata G, Pinto A.

J Neuroimmunol. 2009 Oct 30;215(1-2):84-9. doi: 10.1016/j.jneuroim.2009.06.019. Epub 2009 Aug 19.

PMID:
19695716
11.

Association of aspirin resistance with increased stroke severity and infarct size.

Zheng AS, Churilov L, Colley RE, Goh C, Davis SM, Yan B.

JAMA Neurol. 2013 Feb;70(2):208-13. doi: 10.1001/jamaneurol.2013.601.

PMID:
23165316
12.

Triflusal and aspirin have different effects on inflammatory biomarkers measured in patients with acute ischemic stroke.

Alvarez-Sabín J, Penalba A, Quintana M, Krupinski J, García-Bonilla L, Montaner J.

Cerebrovasc Dis. 2009;28(4):371-7. doi: 10.1159/000230711. Epub 2009 Jul 30.

PMID:
19641312
13.

Pro-inflammatory and anti-inflammatory cytokines in acute ischemic stroke and their relation to early neurological deficit and stroke outcome.

Basic Kes V, Simundic AM, Nikolac N, Topic E, Demarin V.

Clin Biochem. 2008 Nov;41(16-17):1330-4. doi: 10.1016/j.clinbiochem.2008.08.080. Epub 2008 Sep 4.

PMID:
18801351
14.

Caspase-3 is related to infarct growth after human ischemic stroke.

Rosell A, Cuadrado E, Alvarez-Sabín J, Hernández-Guillamon M, Delgado P, Penalba A, Mendioroz M, Rovira A, Fernández-Cadenas I, Ribó M, Molina CA, Montaner J.

Neurosci Lett. 2008 Jan 3;430(1):1-6. Epub 2007 May 6.

PMID:
18055116
15.

Variation and importance of aspirin resistance in patients with known cardiovascular disease.

Poulsen TS, Kristensen SR, Korsholm L, Haghfelt T, Jørgensen B, Licht PB, Mickley H.

Thromb Res. 2007;120(4):477-84. Epub 2006 Dec 22.

PMID:
17188339
16.

Lacunar stroke is associated with diffuse blood-brain barrier dysfunction.

Wardlaw JM, Doubal F, Armitage P, Chappell F, Carpenter T, Muñoz Maniega S, Farrall A, Sudlow C, Dennis M, Dhillon B.

Ann Neurol. 2009 Feb;65(2):194-202. doi: 10.1002/ana.21549.

PMID:
19260033
17.

A pilot study of resistance to aspirin in stroke patients.

Bennett D, Yan B, Macgregor L, Eccleston D, Davis SM.

J Clin Neurosci. 2008 Nov;15(11):1204-9. doi: 10.1016/j.jocn.2008.01.006. Epub 2008 Sep 27.

PMID:
18824358
18.

Exploratory study of plasma total homocysteine and its relationship to short-term outcome in acute ischaemic stroke in Nigerians.

Okubadejo NU, Oladipo OO, Adeyomoye AA, Awosanya GO, Danesi MA.

BMC Neurol. 2008 Jul 12;8:26. doi: 10.1186/1471-2377-8-26.

19.

Major clinical vascular events and aspirin-resistance status as determined by the PFA-100 method among patients with stable coronary artery disease: a prospective study.

Christiaens L, Ragot S, Mergy J, Allal J, Macchi L.

Blood Coagul Fibrinolysis. 2008 Apr;19(3):235-9. doi: 10.1097/MBC.0b013e3282f9ade8.

PMID:
18388505
20.

Remarkable increase in 3-nitrotyrosine in the cerebrospinal fluid in patients with lacunar stroke.

Isobe C, Abe T, Terayama Y.

Brain Res. 2009 Dec 11;1305:132-6. doi: 10.1016/j.brainres.2009.09.108. Epub 2009 Oct 6.

PMID:
19815006

Supplemental Content

Support Center